7 SEPTEMBER
NEW ZEALAND GAZETTE
3001

than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container

Hydrocortisone; and hydrocortisone acetate; in rectal medicines in cream or ointment form containing 1% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of not more than 35 grams per container

Hyoscine; and its salts; in medicines for transdermal use and oral use

Hyoscine-N butyl bromide; in medicines for oral use

Hyoscyamine; and its salts; in medicines containing 0.15% and less of hyoscyamine; except in forms for parenteral use

Ibuprofen; in liquid form for oral use in medicines that have received the Minister’s consent to their distribution as restricted medicines and which are sold in the manufacturer’s original pack containing 200 millilitres or less in volume and in strengths of 100 milligrams or less per 5 millilitres

Insulins

Isoconazole; and it salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

Isoetharine; and its salts; except when contained in medicines for inhalation or for parenteral use

Ketoprofen; and its salts; in tablets or capsules containing 25 mg or less of ketoprofen and in pack sizes of not more than 30 tablets or capsules

Levocabastine

Mercury oxides

Mercury; and its salts; and its compounds

Metoclopramide; when compounded with paracetamol and in a pack size of not more than 10 tablets or capsules

Miconazole; in medicines for buccal use; and for vaginal use when in pack sizes equivalent to one course of treatment

Minoxidil; in medicines for external use

Mupirocin; and its salts

Naproxen; and its salts; in tablets or capsules containing 250 mg or less of naproxen and in pack sizes of not more than 30 tablets or capsules

Nicotinamide; in medicines containing more than 100 mg per dose form

Nicotinic acid; in medicines containing more than 100 mg per dose form

Nicotinyl alcohol; in medicines containing more than 100 mg per dose form

Nitrite, butyl

Nitrite, isobutyl

Nitrite, octyl

Nystatin; in medicines for buccal use; and for vaginal use when in pack sizes equivalent to one course of treatment

Orciprenaline; and its salts; in medicines for oral use

Papaverine; and its salts

Podophyllum extracts; tinctures of podophyllum; podophyllin; in medicines containing 20% or less of podophyllum

Pralidoxime; and its salts

Prochlorperazine; for buccal use in medicines which have received the Minister’s consent to their distribution as restricted medicines and which are sold in the manufacturer’s original pack containing not more than 10 tablets for the treatment of nausea associated with migraine

Quinine; and its salts; in medicines containing 200 mg or less per dose form and in packs containing not more than 5 days’ supply for the treatment of cramp

Reproterol; and its salts; except in medicines for inhalation or for parenteral use

Salbutamol; and its salts; except in medicines for inhalation or for parenteral use

Solanaceous alkaloids; and their salts; in medicines not specified elsewhere in this notice; and in medicines containing 0.15% and less of solanaceous alkaloids calculated as hyoscyamine; except in forms for parenteral use

Sulphacetamide; and its salts; in ophthalmological medicines

Terbutaline; and its salts; except in medicines for inhalation or for parenteral use

Tioconazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

Triamcinolone acetonide; in medicines for buccal use and when in a pack containing 5 mg or less of triamcinolone acetonide

Tulobuterol; and its salts; except in medicines for inhalation or for parenteral use.

Third Schedule

Pharmacy-Only Medicines

Acrivastine

Amethocaine; and its salts; in medicines for external use except in medicines for ophthalmological use

Aminophylline; in liquid form for oral use

Benzocaine; for external use in medicines containing more than 2%

Benzoyl peroxide; in medicines for external use containing more than 5% of benzoyl peroxide

Benzydamine; and its salts

Benzyl benzoate; in medicines containing more than 2.5% of benzyl benzoate

Biphenylacetic acid

Bisacodyl

Bithionol

Bufexamac

Calcium glucono-galacto-gluconate; for parenteral use

Carboxymethylcysteine

Cetirizine; and its salts

Chlophedianol hydrochloride

Ciclopirox; for dermatological use in medicines containing 1% or less of ciclopirox

Cinchocaine; for external use in medicines containing more than 2%

Clidinium; and its salts

Desoxyribonuclease; for external use

Dextranomer

Dextromethorphan; and its salts; in medicines containing more than 0.25% of dextromethorphan

Diclofenac; and its salts; in medicines for external use but not ophthalmological use

Dicyclomine; and its salts

Dimenhydrinate; and its salts; except in a sealed container of not more than 12 tablets or capsules, labelled for the

Next Page →